Popliteal Schwannoma Missed for Years Excised in Hours Under IONM

A popliteal schwannoma that went undiagnosed for years was surgically excised within hours, with intraoperative neuromonitoring (IONM, the real-time electrophysiologic assessment of nerve function during surgery) used to protect the adjacent tibial and common peroneal nerves, according to a case report published in Cureus.

The report, titled "Missed for Years, Cured in Hours: Surgical Excision of a Popliteal Schwannoma With Intraoperative Neuromonitoring," documents the diagnostic delay and successful operative outcome for a patient with a nerve sheath tumor in the popliteal fossa, the anatomical space behind the knee where the sciatic nerve divides into its tibial and peroneal branches.

Schwannomas are benign tumors arising from the Schwann cells that ensheath peripheral nerves. When they develop in the popliteal region, they sit in direct contact with the major motor and sensory pathways of the lower leg. Complete resection is curative, but the proximity of functioning nerve fascicles makes iatrogenic nerve injury the principal operative risk.

What does the monitoring change for the surgical team?

The case underscores the practical function of IONM in peripheral nerve tumor surgery. By delivering intermittent electrical stimulation and recording compound muscle action potentials (the electromyographic response of muscles innervated by the stimulated nerve), the surgical team can confirm nerve identity before incising tissue, map the tumor capsule against functional fascicles, and verify conduction through the nerve after resection is complete.

For neurophysiologists and monitoring staff, the case is a reminder that IONM is not confined to spine and cranial base procedures. Peripheral nerve sheath tumors represent a distinct indication in which free-run and triggered electromyography directly inform the decision of where to cut and where to spare.

Why was the diagnosis delayed for years?

The report's framing — missed for years — points to a recurring clinical problem. Schwannomas of the popliteal fossa can present with nonspecific symptoms, including a palpable mass, localized pain, or paresthesia radiating into the leg, findings that overlap with more common musculoskeletal complaints of the knee. The authors describe a diagnostic course that extended over years before imaging and specialist evaluation established the correct diagnosis.

Once identified, the lesion proved operable in a procedure measured in hours. The contrast between a multi-year diagnostic interval and an operative course of hours is the central fact of the report, and it is the kind of asymmetry that electrophysiology readers will recognize from other slowly enlarging peripheral lesions.

Practice implications

The report contributes a documented example of nerve-sparing excision performed with electrophysiologic guidance in a region where anatomical variation is common and the margin for error is narrow. It does not claim novelty for the technique; IONM-assisted resection of peripheral nerve tumors is an established practice. The value of the publication lies in the illustrated workflow: delayed recognition of a popliteal mass, preoperative localization, monitoring-guided dissection, and postoperative neurologic preservation.

For clinicians who evaluate persistent posterior knee complaints, the case supports early consideration of structural nerve lesions when symptoms do not fit mechanical patterns. For monitoring teams, it illustrates the equipment and montage decisions specific to lower-limb peripheral surgery, where target muscles for recording must be selected according to the nerves at risk in the operative field.

The authors report a cured patient following excision. Cureus, the journal that published the report, is an open-access peer-reviewed clinical journal, and the article is accessible to readers seeking the full operative and electrophysiologic detail.

Further case series with standardized monitoring protocols and long-term neurologic follow-up would help define whether IONM measurably reduces postoperative deficits across peripheral nerve sheath tumors beyond this single documented outcome.